Skip to content
Screener

Gevo GEVO Gevo — Research And Development Expense

Other segment segments

Gevo Fuel Segment
$0
GevoND
$0
Renewable Natural Gas Segment
$0

Similar metrics at other companies

Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%
Helios Technologies logo
HLIOUnallocated Expenses — Research And Development Expense
$0
Dianthus Therapeutics logo
DNTHDiscovery Expenses — Research And Development Expense
$1.36M+51.4%
Innoviva, Inc. logo
INVAInternal Expenses — Research And Development Expense
$2.73M+127%

Other financials

Income statement

See full
Revenue$46.5M+7.1%
Gross profit$26.6M+1.7%
Operating income-$171.7M-3,062%
Net income-$176.9M-8,353%
EPS (diluted)-$0.75-7,600%

Balance sheet

See full
Cash & equivalents$58.1M-54.2%
Total debt$170.7M+3,290%
Total equity$273.2M-42.4%
Total assets$490.7M-31.7%

Cash flow

See full
Operating cash flow-$8.3M-228%
CapEx$12.5M+138%
Free cash flow-$20.8M-167%

Valuation

See full
Market cap$388.16M+29.6%
Enterprise value$500.72M+182%
P/S2.2×-1.6×

Profitability

See full
Gross margin51.2%+6.9pp
Operating margin-102.8%+74.8pp
Net margin-119.9%+221pp
FCF margin-70.9%-33.4pp

Returns & leverage

See full
Return on equity-57%-76.8pp
Debt / equity0.6×+0.6×
Current ratio2.7×+0.4×

Where this comes from

Reported directly by Gevo in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Gevo’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054462
(in thousands)GevoGevo FuelsGevo RNGGevo NDConsolidated
Revenues$1,526$4,447$40,528$46,501
Less:
Depreciation and amortization9231,0574,8046,784
Research and development expense440440
Project development costs1,7244572222,403
Impairment of long-lived assets1,382134,406135,788
Other expenses14,26739,7822,20716,53672,792
Income (loss) from operations(17,210)(174,645)1,18318,966(171,706)

Item 1. Financial Statements (Unaudited)

FAQ

What is Gevo's gevo — research and development expense?
Gevo (GEVO) reported gevo — research and development expense of $440K in Q2 2026.
How has Gevo's gevo — research and development expense changed year-over-year?
Gevo's gevo — research and development expense decreased by 52.9% year-over-year, from $934K to $440K.
What is the long-term trend for Gevo's gevo — research and development expense?
Over 2 years (2023 to 2025), Gevo's gevo — research and development expense has grown at a -16.8% compound annual growth rate (CAGR), from $6.58M to $4.55M.
What does gevo — research and development expense mean?
Captures the costs incurred by a business segment to develop new technologies, improve existing processes, or innovate renewable chemical products. High investment in this area is critical for long-term competitiveness in the biofuels and sustainable energy sector.

Ask your AI about Gevo's gevo — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude